Companies

NATURAL ALTERNATIVES INTERNATIONAL INC

NAII · CIK 0000787253 · operating

$2.75+1.48%Last updated Mar 2, 2:48 PM

Key Statistics

Valuation

Market Cap$16.99M
P/E
Fwd P/E
PEG
P/S0.13
P/B0.25
EV/EBITDA1.45
EV/Rev0.01

Profitability

Gross Margin
Op. Margin
Net Margin
ROE-19.84%
ROA-8.93%
FCF Margin

Financial Health

Current Ratio2.06
Debt/Equity1.22
Free Cash Flow$2.32M
Div. Yield

Growth & Other

Revenue Growth
EPS Growth-85.37%
Beta0.34
52W High$4.96
52W Low$2.33

About NATURAL ALTERNATIVES INTERNATIONAL INC

Natural Alternatives International operates as a contract manufacturer and ingredient supplier for the nutritional supplements industry. The company formulates, manufactures, and markets vitamins, minerals, herbal supplements, and related health care products, serving customers across direct sales, e-commerce, and retail distribution channels. Its manufacturing capabilities span multiple product formats including capsules, tablets, chewable wafers, and powders. The company also markets beta-alanine ingredients under proprietary brand names including CarnoSyn, TriBsynm, and SR CarnoSyn.

The business operates through two primary segments: Private-Label Contract Manufacturing and Patent and Trademark Licensing. The contract manufacturing segment provides white-label production services alongside ancillary support functions such as product formulation, clinical study design, packaging and labeling design, regulatory compliance, and international product registration assistance. This segment serves manufacturers that require outsourced production capabilities for their supplement portfolios.

Headquartered in Carlsbad, California, the company operates with approximately 293 full-time employees and maintains an international presence, serving customers across the United States and other markets. Founded in 1980, the company is incorporated in Delaware and trades on the Nasdaq exchange.

Earnings Per Share (Annual · SEC XBRL)

Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.

Fiscal YearEPS DilutedEPS BasicYoY
2025$-2.28$-2.28-85.4%
2024$-1.23$-1.23-386.0%
2023$0.43$0.43-75.3%
2022$1.74$1.75+3.0%
2021$1.69$1.71+776.0%
2020$-0.25$-0.25-127.2%
2019$0.92$0.96+26.0%
2018$0.73$0.76-33.0%
2017$1.09$1.10-24.3%
2016$1.44$1.46+193.9%
2015$0.49$0.50+69.0%
2014$0.29$0.29+26.1%
2013$0.23$0.23-61.0%
2012$0.59$0.60

Annual Reports (10-K) · 28 filings

Report DateFiledAccession Number
2025-06-302025-09-230001437749-25-029731SEC ↗
2024-06-302024-09-270001437749-24-030208SEC ↗
2023-06-302023-09-210001437749-23-026521SEC ↗
2022-06-302022-09-210001437749-22-022855SEC ↗
2021-06-302021-09-200001437749-21-022419SEC ↗
2020-06-302020-09-210001437749-20-019951SEC ↗
2019-06-302019-09-240001437749-19-018974SEC ↗
2018-06-302018-09-190001437749-18-017202SEC ↗
2017-06-302017-09-180001437749-17-016018SEC ↗
2016-06-302016-09-190001437749-16-038893SEC ↗
2015-06-302015-09-180001437749-15-017483SEC ↗
2014-06-302014-09-250001437749-14-017442SEC ↗
2013-06-302013-09-190001193125-13-371742SEC ↗
2012-06-302012-09-210001193125-12-399915SEC ↗
2011-06-302011-09-220001193125-11-254365SEC ↗
2010-06-302010-09-170001193125-10-212298SEC ↗
2009-06-302009-09-280001193125-09-198370SEC ↗
2008-06-302008-09-220001193125-08-199297SEC ↗
2007-06-302007-10-150001193125-07-218421SEC ↗
2006-06-302006-09-180001193125-06-191942SEC ↗
2005-06-302005-09-080001193125-05-182282SEC ↗
2004-06-302004-09-140001193125-04-156242SEC ↗
2003-06-302003-09-170001193125-03-050762SEC ↗
2002-06-302002-09-230000898430-02-003502SEC ↗
1999-06-301999-09-280000936392-99-001148SEC ↗
1998-06-301998-09-280000936392-98-001292SEC ↗
1997-06-301997-09-290000936392-97-001256SEC ↗
1996-06-301996-09-270000936392-96-000812SEC ↗